Determination of Susceptibility Rates of Nosocomial Acinetobacter baumannii Isolates to Sulbactam by E-test Method

Introduction: Bacteria of the genus Acinetobacter play an important role as causative agents of hospital-acquired infections. Multidrug-resistant Acinetobacter infections have increasingly been observed worldwide. In parallel with the increasing rate of infections, therapeutic options are becoming limited. Although the susceptibility rates are not exactly known, sulbactam alone or sulbactam with ampicillin play a part in combination therapies against Acinetobacter infections. This study aimed to determine the minimum inhibitory concentrations (MICs) of sulbactam against multidrug-resistant Acinetobacter baumannii strains using the E-test method and to deduce the susceptibility rates based on literature data. Materials and Methods: The study included 100 multidrug-resistant A. baumannii strains isolated from clinical samples obtained from patients hospitalized in intensive care units of the Ministry of Health Ankara Training and Research Hospital between June 15, 2011 and June 15, 2013. Antibiotic susceptibility testing and strain identification were performed using conventional methods and the VITEK 2 (bioMerieux SA, France) system. Resistance to three or more drugs was considered as multidrug resistance. MIC, MIC50, and MIC90 values (mu g/mL) of sulbactam against the 100 isolates were determined using the E test method. Since the breakpoint MIC of sulbactam against Acinetobacter had not been established, the susceptibility rates were estimated based on the MIC values reported in the literature (<= 4 or 8 mu g/mL). Results: The MIC values of sulbactam against the Acinetobacter isolates ranged widely (between 1 and 256 mu g/mL), and the MIC50 and MIC90 values were determined to be 12 and 96 mu g/mL, respectively. When 8 mu g/mL was considered as the susceptibility breakpoint, 44% of the isolates were found to be susceptible; however, the rate was only 21% when 4 mu g/mL was considered as the breakpoint. Conclusion: Based on its MIC values determined in our study, sulbactam appeared to be a promising agent for the treatment of infections caused by multidrug-resistant A. baumannii isolates. Nonetheless, more studies are needed, especially on its clinical effectiveness.

Yazar Temocin, Fatih
Tulek, Necla
Erdinc, F. Sebnem
Hekimoglu, Sirin
Demirelli, Meryem
Ertem, Gunay
Sahin, Hunkar
Yayın Türü Article
Tek Biçim Adres https://hdl.handle.net/20.500.12628/2367
Tek Biçim Adres 10.5578/flora.46501
Konu Başlıkları Sulbactam
Acinetobacter baumannii
E-test
Koleksiyonlar Araştırma Çıktıları | WoS | Scopus | TR-Dizin | PubMed | SOBİAD
WoS İndeksli Yayınlar Koleksiyonu
Dergi Adı FLORA-INFEKSIYON HASTALIKLARI VE KLINIK MIKROBIYOLOJI DERGISI
Dergi Cilt Bilgisi 22
Dergi Sayısı 1
Sayfalar 11 - 16
Yayın Yılı 2017
Eser Adı
[dc.title]
Determination of Susceptibility Rates of Nosocomial Acinetobacter baumannii Isolates to Sulbactam by E-test Method
Yazar
[dc.contributor.author]
Temocin, Fatih
Yazar
[dc.contributor.author]
Tulek, Necla
Yazar
[dc.contributor.author]
Erdinc, F. Sebnem
Yazar
[dc.contributor.author]
Hekimoglu, Sirin
Yazar
[dc.contributor.author]
Demirelli, Meryem
Yazar
[dc.contributor.author]
Ertem, Gunay
Yazar
[dc.contributor.author]
Sahin, Hunkar
Yayın Yılı
[dc.date.issued]
2017
Yayıncı
[dc.publisher]
BILIMSEL TIP YAYINEVI
Yayın Türü
[dc.type]
article
Özet
[dc.description.abstract]
Introduction: Bacteria of the genus Acinetobacter play an important role as causative agents of hospital-acquired infections. Multidrug-resistant Acinetobacter infections have increasingly been observed worldwide. In parallel with the increasing rate of infections, therapeutic options are becoming limited. Although the susceptibility rates are not exactly known, sulbactam alone or sulbactam with ampicillin play a part in combination therapies against Acinetobacter infections. This study aimed to determine the minimum inhibitory concentrations (MICs) of sulbactam against multidrug-resistant Acinetobacter baumannii strains using the E-test method and to deduce the susceptibility rates based on literature data. Materials and Methods: The study included 100 multidrug-resistant A. baumannii strains isolated from clinical samples obtained from patients hospitalized in intensive care units of the Ministry of Health Ankara Training and Research Hospital between June 15, 2011 and June 15, 2013. Antibiotic susceptibility testing and strain identification were performed using conventional methods and the VITEK 2 (bioMerieux SA, France) system. Resistance to three or more drugs was considered as multidrug resistance. MIC, MIC50, and MIC90 values (mu g/mL) of sulbactam against the 100 isolates were determined using the E test method. Since the breakpoint MIC of sulbactam against Acinetobacter had not been established, the susceptibility rates were estimated based on the MIC values reported in the literature (<= 4 or 8 mu g/mL). Results: The MIC values of sulbactam against the Acinetobacter isolates ranged widely (between 1 and 256 mu g/mL), and the MIC50 and MIC90 values were determined to be 12 and 96 mu g/mL, respectively. When 8 mu g/mL was considered as the susceptibility breakpoint, 44% of the isolates were found to be susceptible; however, the rate was only 21% when 4 mu g/mL was considered as the breakpoint. Conclusion: Based on its MIC values determined in our study, sulbactam appeared to be a promising agent for the treatment of infections caused by multidrug-resistant A. baumannii isolates. Nonetheless, more studies are needed, especially on its clinical effectiveness.
Açıklama
[dc.description]
WOS: 000458956900002
Kayıt Giriş Tarihi
[dc.date.accessioned]
2019-12-23
Açık Erişim Tarihi
[dc.date.available]
2019-12-23
Yayın Dili
[dc.language.iso]
eng
Konu Başlıkları
[dc.subject]
Sulbactam
Konu Başlıkları
[dc.subject]
Acinetobacter baumannii
Konu Başlıkları
[dc.subject]
E-test
Haklar
[dc.rights]
info:eu-repo/semantics/openAccess
ISSN
[dc.identifier.issn]
1300-932X
İlk Sayfa Sayısı
[dc.identifier.startpage]
11
Son Sayfa Sayısı
[dc.identifier.endpage]
16
Dergi Adı
[dc.relation.journal]
FLORA-INFEKSIYON HASTALIKLARI VE KLINIK MIKROBIYOLOJI DERGISI
Dergi Sayısı
[dc.identifier.issue]
1
Dergi Cilt Bilgisi
[dc.identifier.volume]
22
Tek Biçim Adres
[dc.identifier.uri]
https://dx.doi.org/10.5578/flora.46501
Tek Biçim Adres
[dc.identifier.uri]
https://hdl.handle.net/20.500.12628/2367
Görüntülenme Sayısı ( Şehir )
Görüntülenme Sayısı ( Ülke )
Görüntülenme Sayısı ( Zaman Dağılımı )
Görüntülenme
24
09.12.2022 tarihinden bu yana
İndirme
1
09.12.2022 tarihinden bu yana
Son Erişim Tarihi
09 Şubat 2024 09:39
Google Kontrol
Tıklayınız
sulbactam Acinetobacter infections susceptibility values against isolates determined breakpoint multidrug-resistant baumannii considered clinical strains method literature system Resistance resistance multidrug estimated established Introduction reported treatment appeared promising caused Nonetheless studies needed especially effectiveness Conclusion Results
6698 sayılı Kişisel Verilerin Korunması Kanunu kapsamında yükümlülüklerimiz ve çerez politikamız hakkında bilgi sahibi olmak için alttaki bağlantıyı kullanabilirsiniz.

creativecommons
Bu site altında yer alan tüm kaynaklar Creative Commons Alıntı-GayriTicari-Türetilemez 4.0 Uluslararası Lisansı ile lisanslanmıştır.
Platforms